Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Patt

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
JCO Oncology Practice|January 12, 2021
Telemedicine in Community Cancer Care: How Technology Helps Patients With Cancer Navigate a PandemicDebra A Patt, Lalan Wilfong, Sara Toth, et al.
The American Journal of Managed Care|June 30, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Journal of Oncology Practice|September 3, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Native microbiome impedes vertical transmission of Wolbachia in Anopheles mosquitoesGrant L Hughes, Brittany L Dodson, Rebecca M Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Carey K Anders, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline UpdateSharon H Giordano, Sarah Temin, Sarat Chandarlapaty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2019
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancerM Oliveira, C Saura, P Nuciforo, et al.
JCO Oncology Practice|December 22, 2020
New Landscape: Physician CompensationChristian A Thomas, Allison M Hirschorn, Julia E Tomkins, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
JCO Oncology Practice|January 12, 2021
Telemedicine in Community Cancer Care: How Technology Helps Patients With Cancer Navigate a PandemicDebra A Patt, Lalan Wilfong, Sara Toth, et al.
The American Journal of Managed Care|June 30, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in 2 distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Journal of Oncology Practice|September 3, 2011
Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databasesJ Russell Hoverman, Thomas H Cartwright, Debra A Patt, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 13, 2014
Native microbiome impedes vertical transmission of Wolbachia in Anopheles mosquitoesGrant L Hughes, Brittany L Dodson, Rebecca M Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Management of Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Guideline UpdateNaren Ramakrishna, Carey K Anders, Nancy U Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 31, 2022
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Guideline UpdateSharon H Giordano, Maria Alice B Franzoi, Sarah Temin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: ASCO Clinical Practice Guideline UpdateSharon H Giordano, Sarah Temin, Sarat Chandarlapaty, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2018
Recommendations on Disease Management for Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Brain Metastases: ASCO Clinical Practice Guideline UpdateNaren Ramakrishna, Sarah Temin, Sarat Chandarlapaty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2019
FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancerM Oliveira, C Saura, P Nuciforo, et al.
JCO Oncology Practice|December 22, 2020
New Landscape: Physician CompensationChristian A Thomas, Allison M Hirschorn, Julia E Tomkins, et al.
Pageof 6